# Clinical Evaluation of the Efficacy and Safety of a Medical Device in the Form of Rectal Suppositories (Prospidol®) for the Treatment of Symptoms Associated With Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

> **NCT07685847** · NA · COMPLETED · sponsor: **S&R Farmaceutici S.p.A.** · enrollment: 40 (actual)

## Conditions studied

- Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

## Interventions

- **DEVICE:** Prospidol suppository

## Key facts

- **NCT ID:** NCT07685847
- **Lead sponsor:** S&R Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-01
- **Primary completion:** 2026-07-24
- **Final completion:** 2026-07-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685847, "Clinical Evaluation of the Efficacy and Safety of a Medical Device in the Form of Rectal Suppositories (Prospidol®) for the Treatment of Symptoms Associated With Chronic Prostatitis/Chronic Pelvic Pain Syndrome.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07685847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*